HOW TO ACHIEVE GOOD RESULTS€¦ · • Planned radiation therapy to the breast following breast...

S E S P R S 2 0 1 935 T H A N N UA L AT L A NTA BRE AST SU RG ERY SYM P OS I U M

H O W T O A C H I E V EG O O D R E S U LT SA F T E R C O M M O N C O M P L I C A T I O N S

J A N U A R Y 1 8 – 2 0 , 2 0 1 9T H E I N T E R C O N T I N E N TA L H O T E L | AT L A N TA , G E O R G I A

© 2018 Allergan. All rights reserved. All trademarks are the property of their respective owners. Natrelle.com NAT113068_v3 08/18 181943

Mina Actual breast cancer and breast reconstruction patient with Natrelle INSPIRA® Breast Implants.Individual results may vary.

When I look in the mirror now,

I JUST SEE ME.”“

Only Natrelle®

DOES GUMMY LIKE THISNatrelle INSPIRA® Cohesive

Natrelle INSPIRA® SoftTouch

Natrelle INSPIRA® Responsive

Cohe

sivity Level

1

Cohe

sivity Level

2

Cohe

sivity Level

3

*600 breast implant options.Three cohesivities. Countless possibilities.1,*

Natrelle® Breast Implants Important Information

INDICATIONS Natrelle® Breast Implants are indicated for women for the following:Breast reconstruction. Breast reconstruction includes primary reconstruction to replace breast tissue that has been removed due to cancer or trauma or that has failed to develop properly due to a severe breast abnormality. Breast reconstruction also includes revision surgery to correct or improve the result of a primary breast reconstruction surgery.

IMPORTANT SAFETY INFORMATION CONTRAINDICATIONS Breast implant surgery should not be performed in:• Women with active infection anywhere in their body.• Women with existing cancer or precancer of their breast who have not received

adequate treatment for those conditions.• Women who are currently pregnant or nursing.

WARNINGS • Breast implants are not lifetime devices or necessarily a one-time surgery.• Avoid damage during surgery: Care should be taken to avoid the use of excessive

force and to minimize handling of the implant. Use care when using surgical instruments in proximity with the breast implant. For more information, please see the full Directions for Use.

PRECAUTIONS Safety and effectiveness have not been established in patients with the following:• Autoimmune diseases (eg, lupus and scleroderma).• A compromised immune system (eg, currently receiving immunosuppressive therapy).

• Planned chemotherapy following breast implant placement.• Planned radiation therapy to the breast following breast implant placement.• Conditions or medications that interfere with wound healing and blood clotting.• Reduced blood supply to breast tissue.• Clinical diagnosis of depression or other mental health disorders, including body

dysmorphic disorder and eating disorders. Please discuss any history of mental health disorders prior to surgery. Patients with a diagnosis of depression, or other mental health disorders, should wait until resolution or stabilization of these conditions prior to undergoing breast implantation surgery.

ADVERSE EVENTS Key adverse events are reoperation, implant removal with or without replacement, implant rupture with silicone-filled implants, and capsular contracture Baker Grade III/IV.

Other potential adverse events that may occur with breast implant surgery include: asymmetry, breast pain, breast/skin sensation changes, capsular calcification, delayed wound healing, hematoma, hypertrophic scarring/scarring, implant extrusion, implant malposition, implant palpability/visibility, infection, nipple complications, redness, seroma, swelling, tissue/skin necrosis, wrinkling/rippling.

For more information see the full Directions for Use at www.allergan.com /labeling/usa.htm. To report a problem with Natrelle® Breast Implants, please call Allergan at 1-800-433-8871.

Natrelle® Breast Implants are available by prescription only.

Reference: 1. Data on file, Allergan, January 2018; Allergan Plastic Surgery Order Form.

SUPPORTING WOMEN AND THEIR

BREAST CANCER JOURNEYS

Contact your Allergan sales representative or visit NatrelleSurgeon.com to learn more. #MyReconReason

181585_SESPRS_Resize_Ad_ST.indd 1 11/15/18 3:57 PM

T H E I N T E R C O N T I N E N T A L H O T E L | A T L A N T A , G E O R G I A 3

2 0 1 9 S C I E N T I F I C P R O G R A M

SYMPOSIUM CHAIRS

Program Chair

Mark A. Codner, MD— Clinical Assistant Professor, Emory University Atlanta, GA

Program Co-Chairs

James D. Namnoum, MD— Clinical Assistant Professor, Emory University Atlanta, GA

Albert Losken, MD— William G. Hamm Professor of Plastic Surgery, Emory Plastic Surgery Program Director, Emory University Atlanta, GA

Emeritus Chairs

L. Franklyn Elliott, MD— Private Practice Atlanta, GA

Carl R. Hartrampf, Jr., MD— Retired Atlanta, GA

SYMPOSIUM FACULTY

Amy Alderman, MD— Private Practice Atlanta, GA

Mitchell Brown, MD— Plastic and Reconstructive Surgeon, University of Toronto Toronto, Canada

Louis P. Bucky, MD— Clinical Professor of Surgery, Division of Plastic Surgery, University of Pennsylvania School of Medicine, Chief of Plastic Surgery, Pennsylvania Hospital Philadelphia, PA

M. Bradley Calobrace, MD— Clinical Faculty in Plastic Surgery, University of Louisville and University of Kentucky Louisville & Lexington, KY

Abhishek Chatterjee, MD— Chief of the Division of Plastic Surgery, Division of Surgical Oncology, Tufts Medical Center Boston, MA

Mark Clemens, MD— Associate Professor Plastic Surgery, MD Anderson Cancer Center Houston, TX

Elizabeth Hall-Findlay, MD— Banff Plastic Surgery Alberta, Canada

Dennis C. Hammond, MD— Partners in Plastic Surgery Grand Rapids, MI

Kent K. Higdon, MD— Associate Professor, Dept of Plastic Surgery, Vanderbilt University Nashville, TN

Ram Kalus, MD— Plastic Surgery of The Carolinas Mount Pleasant, SC

Suhail Kanchwala, MD—Associate Professor of Surgery, University of Pennsylvania Hospital, Chief of Plastic Surgery Philadelphia, PA

John Kim, MD— Professor, Division of Plastic and Reconstructive Surgery, Northwestern University, Feinberg School of Medicine Chicago, IL

Peter Lennox, MD— Head, Division of Plastic Surgery, University of British Columbia Vancouver, Canada

Patrick Mallucci, MD— Private Practice South Kensington, London

Maurice Nahabedian MD— Professor of Plastic Surgery, VCU School of Medicine McLean, VA

Peter Per Heden, MD— Associate Professor in Plastic Surgery Stockholm, Sweden

Tracy M. Pfeifer, MD— Private Practice New York, NY

Troy Pittman, MD— Plastic and Reconstructive Surgeon, PittmanMD—Advanced Plastic Surgery Washington, DC

Kenneth Shestak, MD— Professor, Division of Plastic Surgery, University of Pittsburgh School of Medical Center Pittsburgh, PA

Steven A. Teitelbaum, MD— Associate Clinical Professor of Plastic Surgery, David Geffen School of Medicine UCLA Santa Monica, CA

Jennifer L. Walden, MD— Clinical Assistant Professor, UTSW Department of Plastic Surgery, Private Practice Austin, TX

Simeon Wall, Jr., MD—Director, The Wall Center for Plastic Surgery; Assistant Clinical Professor, Department of Plastic Surgery, UT Southwestern Medical Center; Assistant Clinical Professor, Division of Plastic Surgery, LSUHSC at Shreveport Shreveport, LA

AMERICAN PLASTIC SURGERY SOCIETY UPDATES

ASAPS Jennifer Walden, MD Austin, TX

ASPS Andrea Pusic, MD Boston, MA

SESPRS Stephan J. Finical, MD Charlotte, NC

© 2018 Allergan. All rights reserved. All trademarks are the property of their respective owners. Natrelle.com NAT113068_v3 08/18 181943

Mina Actual breast cancer and breast reconstruction patient with Natrelle INSPIRA® Breast Implants.Individual results may vary.

When I look in the mirror now,

I JUST SEE ME.”“

Only Natrelle®

DOES GUMMY LIKE THISNatrelle INSPIRA® Cohesive

Natrelle INSPIRA® SoftTouch

Natrelle INSPIRA® Responsive

Cohe

sivity Level

1

Cohe

sivity Level

2

Cohe

sivity Level

3

*600 breast implant options.Three cohesivities. Countless possibilities.1,*

Natrelle® Breast Implants Important Information

INDICATIONS Natrelle® Breast Implants are indicated for women for the following:Breast reconstruction. Breast reconstruction includes primary reconstruction to replace breast tissue that has been removed due to cancer or trauma or that has failed to develop properly due to a severe breast abnormality. Breast reconstruction also includes revision surgery to correct or improve the result of a primary breast reconstruction surgery.

IMPORTANT SAFETY INFORMATION CONTRAINDICATIONS Breast implant surgery should not be performed in:• Women with active infection anywhere in their body.• Women with existing cancer or precancer of their breast who have not received

adequate treatment for those conditions.• Women who are currently pregnant or nursing.

WARNINGS • Breast implants are not lifetime devices or necessarily a one-time surgery.• Avoid damage during surgery: Care should be taken to avoid the use of excessive

force and to minimize handling of the implant. Use care when using surgical instruments in proximity with the breast implant. For more information, please see the full Directions for Use.

PRECAUTIONS Safety and effectiveness have not been established in patients with the following:• Autoimmune diseases (eg, lupus and scleroderma).• A compromised immune system (eg, currently receiving immunosuppressive therapy).

• Planned chemotherapy following breast implant placement.• Planned radiation therapy to the breast following breast implant placement.• Conditions or medications that interfere with wound healing and blood clotting.• Reduced blood supply to breast tissue.• Clinical diagnosis of depression or other mental health disorders, including body

dysmorphic disorder and eating disorders. Please discuss any history of mental health disorders prior to surgery. Patients with a diagnosis of depression, or other mental health disorders, should wait until resolution or stabilization of these conditions prior to undergoing breast implantation surgery.

ADVERSE EVENTS Key adverse events are reoperation, implant removal with or without replacement, implant rupture with silicone-filled implants, and capsular contracture Baker Grade III/IV.

Other potential adverse events that may occur with breast implant surgery include: asymmetry, breast pain, breast/skin sensation changes, capsular calcification, delayed wound healing, hematoma, hypertrophic scarring/scarring, implant extrusion, implant malposition, implant palpability/visibility, infection, nipple complications, redness, seroma, swelling, tissue/skin necrosis, wrinkling/rippling.

For more information see the full Directions for Use at www.allergan.com /labeling/usa.htm. To report a problem with Natrelle® Breast Implants, please call Allergan at 1-800-433-8871.

Natrelle® Breast Implants are available by prescription only.

Reference: 1. Data on file, Allergan, January 2018; Allergan Plastic Surgery Order Form.

SUPPORTING WOMEN AND THEIR

BREAST CANCER JOURNEYS

Contact your Allergan sales representative or visit NatrelleSurgeon.com to learn more. #MyReconReason

181585_SESPRS_Resize_Ad_ST.indd 1 11/15/18 3:57 PM

F R I D A Y – S U N D A Y | J A N U A R Y 1 8 – 2 0 , 2 0 1 94

3 5 T H A N N U A L A T L A N T A B R E A S T S U R G E R Y S Y M P O S I U M

SPONSORED BY:The Southeastern Society of Plastic and Reconstructive Surgeons (SESPRS)

“Advancing professional excellence, quality education, and regional collegiality”

ENDORSED BY:

PROGRAM OBJECTIVES

At the completion of this CME activity, registrants will be able to:

• Enhance and expand surgical technique in cases like transgender breast surgery, double bubble following breast augmentation, and autologous breast reconstruction with contralateral reduction,

• Discuss strategies to improve various breast reconstruction techniques,

• Assess advantages and disadvantages to improve techniques related to Implants, expanders, and ADM use in pre-pectoral breast reconstruction,

• Review up to date information on fat grafting to the breast for reconstructive procedures,

• Identify alternative ideas in breast reconstruction,

• Update on ALCL, the role of textured implants, and optimizing outcomes

• Improve the strategies in management of breast augmentation and mastopexy to maximize results and minimize complications,

• Review current perspectives in transgender surgery,

• Discuss strategies to communicate and satisfy the unhappy patient,

• Review safety and management of complications of oncoplastic breast surgery to improve outcomes.

THE 2019 HONORARY HARTRAMPF LECTURE:Elizabeth Hall-Findlay, MD—“Reflections”

THE 2019 INTERNATIONAL SCHOLARS PROGRAM:The Southeastern Society of Plastic and Reconstructive Surgeons provides generous funding to different countries each year to sponsor the travel and registration expenses to the top three (3) Plastic Surgery Chief Residents in that country. This Southeastern honor provides them with a unique international educational outreach. The 2019 Foreign Scholars are invited from The Eastern European Country of Georgia. Nodar Brunjadze, MD; Elene Pateishvili, MD; Mariam Topuria, MD



6:00–8:00 pmWelcome Reception and Early RegistrationIntercontinental HotelWindsor Ballroom Foyer

7:00–8:00 amRegistration Continental Breakfast/Visit Exhibits Windsor Ballroom Foyer

8:00 amSESPRS WELCOMEStephan J. Finical, MD, President SESPRS

8:00–12:00 pmLIVE SURGERY TELECAST Moderator—Codner

Room 1 Northside Hospital Observers—Alderman, Mallucci, Per Heden

8:00 am Brown—Transgender Breast Augmentation

10:00 am Calobrace—“Double Bubble” Correction after Prior Breast Augmentation

Room 2 Northside Hospital Observers—Shestak, Lennox, Kim

8:00 amLosken—Breast Reconstruction with Autologous Mastectomy Flaps and Contralateral Breast Reduction

Live Surgery Generously Supported by Northside Hospital

FRIDAY, JANUARY 18, 2019

THURSDAY, JANUARY 17, 2019



12:00–1:00 pmLunchHope and Trippe Ballrooms

1:00 pmOpening Remarks Mark A. Codner, MD—Program Chairman

1:00–2:00 pmAUTOLOGOUS BREAST RECONSTRUCTION Moderator—Elliott

1:00–1:15 pm Elliott—The TRAM Flap in 2019

1:15–1:30 pmHigdon—Team Based Care and Enhanced Recovery Pathways to Improve DIEP Flap Breast Reconstruction

1:30–1:45 pmKanchwala—Surgical Delay and Laparoscopic Harvestof DIEP Flap Perforators

1:45–2:00 pm Nahabedian—Autologous Breast Reconstruction Combined with Implants

2:00–2:15 pm Discussion

2:15–2:45 pmHONORARY HARTRAMPF LECTURE Introduction—LoskenElizabeth Hall-Findlay, MD—“Reflections”

2:45–3:15 pm Coffee Break/Visit Exhibits Windsor Ballroom Foyer

3:15–4:15 pmIMPLANT/EXPANDER/ADM/PREPECTORAL RECONSTRUCTIONModerator—Losken

3:15–3:30 pm Kalus—Optimizing Outcomes in Direct to Implant Reconstruction

3:30–3:45 pmNamnoum—Composite ADM and Mesh in Prepectoral Direct to Implant Reconstruction

pIdentified as applicable to patient safety

.25

.25




3:45–4:00 pmPittman—The P1 Method: Preventing Rippling and Implant Visibility in Prepectoral Implant Reconstruction

4:00–4:15 pmShestak—An Algorithmic Approach to Implant Reconstruction Following Previous Breast Augmentation


4:30–5:30 pmPANEL—FAT GRAFTING FOR BREAST RECONSTRUCTIONModerator—Namnoum

4:30–4:45 pm Brown—Fat as a Solution to Implant Complications

4:45–5:00 pmBucky—Complications in Large Volume Fat Grafting: Risk Factors and Management

5:00–5:15 pmKim—Safety and Efficacy of Fat Grafting to theReconstructed Breast


5:30–6:30 pmALTERNATIVE IDEAS IN BREAST RECONSTRUCTIONModerator—Losken

5:30–5:45 pmKim—Taking the Bull By the Horns: Embracing Radiation in Breast Reconstruction

5:45–6:00 pm Losken—Safer Options for Large Breast Reconstruction

6:00–6:15 pm Kalus—Managing Difficult Complications in Breast Reconstruction


7:30–10:00 pmGALA DINNERVenetian Ballroom


.25

.25

.25

.25

.25

.25



7:00–8:00 amContinental Breakfast/Visit ExhibitsWindsor Ballroom Foyer

8:00–8:30 amAmerican Plastic Surgery Society UpdatesModerator—Stephan J. Finical, MD

ASPS—Andrea Pusic, MDASAPS—Jennifer Walden, MDSESPRS—Stephan J. Finical, MD

8:30–9:45 amPANEL—ROLE OF TEXTURED IMPLANTS IN THE ERA OF BIA-ALCL Moderator—Namnoum

8:30–8:50 am Clemons—An Update on ALCL

8:50–9:05 am Lennox—Profile of BIA-ALCL in Canada

9:05–9:20 am Brown—Where Textured Implants Fit Into My Practice

9:20–9:35 am Calobrace—Why I Prefer Textured Implants for Breast Surgery

9:35–9:45 am Discussion

9:45–10:15 amCoffee Break/Visit ExhibitsWindsor Ballroom Foyer

10:15–11:45 amBREAST AUGMENTATION AND MASTOPEXYModerator—Elliott

10:15–10:30 amWall —Long Term Results in Single Stage Short Scar Mastopexy Augmentation

10:30–10:45 amNamnoum—Mastopexy with Augmentation and Fat Grafting—Why I Prefer the Graf Technique

SATURDAY, JANUARY 19, 2019




10:45–11:00 am Calobrace—Mastopexy with Augmentation and Fat Grafting

11:00–11:15 am Per Heden—Mastopexy Augmentation in Secondary Cases

11:15–11:30 am Mallucci—Mastopexy Augmentation: It is All About the Flop


11:45–12:35 pmBREAST AUGMENTATIONModerator—Codner

11:45–11:55 am Malluci—Round vs. Anatomic Implants

11:55–12:05 pm Lennox—Optimizing Outcomes with Smooth Implants

12:05–12:15 pmHammond—Prevention and Management of Bottoming Out After Breast Augmentation

12:15–12:25 pmPer Heden—Evolution, Refinements and Indications for theNeo Submuscular Breast Augmentation


12:35–1:30 pmLunchHope and Trippe Ballrooms

1:30–1:45 pmINTERNATIONAL SCHOLARS’ AWARDS—GEORGIAModerator—Codner

Nodar Brunjadze, MD . . . . . . . . . . . . . GeorgiaElene Pateishvili, MD . . . . . . . . . . . . . GeorgiaMariam Topuria, MD . . . . . . . . . . . . . . Georgia



.25



1:45–2:00 pm JOHN BOSTWICK RESIDENT PAPER AWARDModerator – LoskenDoes Staged Breast Reduction Prior to Nipple-Sparing Mastectomy Decrease Complications? A Matched Cohort Study Between Staged and Non-Staged TechniquesAra Salibian, MD—New York University Langone Health

2:00–2:15 pm 2018 BREAST SYMPOSIUM LIVE SURGERY RESULTSModerator—Namnoum

Adams—Mastopexy Augmentaiton with MeshBuchel—Delayed Breast Reconstruction with DIEP FlapKenkel—Male Breast Reduction

2:15–3:15 pmPANEL—TRANSGENDER BREAST SURGERYModerator—Losken

2:15–2:30 pm Pittman—Unique Considerations in Transgender Breast Augmentation

2:30–2:45 pm Walden—Male to Female Breast Surgery—A Feminine Perspective

2:45–3:00 pmBrown—Breast Surgery in the Transgender Patient: The Toronto Experience


3:15–4:15 pmTHE DIFFICULT BREAST SURGERY PATIENTModerator—Elliott

3:15–3:30 pmTeitelbaum—Converting the Unhappy Patient with Smooth Hard Implants Into an Angry Patient with Rippled Soft Breasts

3:30–3:45 pmBucky—What I’ve Learned About Unhappy Patients After 25 Years of Practice

3:45–4:00 pmAlderman—How to Satisfy the Unhappy Breast Augmentation Patient




.25

.25





SUNDAY, JANUARY 20, 2019

4:15–5:45 pmBREAST REDUCTION AND MASTOPEXYModerator—Codner

4:15–4:30 pm Bucky—Peri-areolar Mastopexy—Is it Really as Bad as Reported?

4:30–4:45 pm Calobrace—Is There an Indication for Peri-areolar Mastopexy

4:45–5:00 pmHammond—Managing Shape Change after Mastopexy and the Power of the Vertical Technique

5:00–5:15 pmTeitelbaum—How to Make the Wise Pattern Superior to the Vertical Mastopexy and Reduction

5:15–5:30 pm Codner—Superior Pedicle Breast Reduction


7:00–8:00 amContinental Breakfast/Visit Exhibits Windsor Ballroom Foyer

8:00–9:30 amONCOPLASTIC BREAST SURGERYModerator—Losken

8:00–8:15 amChatterjee—Management of Complications Following Oncoplastic Surgery

8:15–8:30 am Nahabedian—The Oncological Safety of Oncoplastic Surgery

8:30–8:45 am Losken—Extreme Oncoplastic Reductions

.20



SUNDAY, JANUARY 20, 2019

8:45–9:00 am Chatterjee—Managing Positive Margins after Oncoplastic Surgery


9:15–10:15 amPROBLEM CASES FROM THE EXPERTS; LOWERING THE IMF: SITING, STABILIZING, AND SELECTINGModerator—Namnoum

9:15–9:25 am Hammond—Setting the IMF for Long Term Stability

9:25–9:35 amPer Heden—My Analysis for Proper Fold Placement— The Stockholm Method

9:35–9:45 amMallucci—The ICE Principle for the Proper Location of the Fold—The Implant Makes a Difference

9:45–9:55 am Wall—Selecting the Proper Position of the IMF

9:55–10:05 am Alderman—Nipple Position Relative to the IMF


10:15–10:45 amCoffee Break/Visit Exhibits Windsor Ballroom Foyer

10:45–12:30 pmHOT TOPICS IN BREAST SURGERYModerator—Codner

10:45–10:55 am Wall—Expansion Vibration Lipofilling in Aesthetic Breast Surgery

10:55–11:05 am Kanchwala—BOOM Flaps: Hybrid Autologous Breast Reconstruction

11:05–11:15 am Pfeifer—Minimizing Capsular Contracture—Evidence Approach

11:15–11:25 am Clemens—Achieving High Reliability in DIEP Flap Reconstructions


.20



SUNDAY, JANUARY 20, 201911:25–11:30 am Discussion

11:30–11:40 am Teitelbaum—Pectoralis 1 and 2 Blocks for Breast Surgery

11:40–11:50 am Walden—Radiofrequency-Assisted Liposuction to Lift the Breast

11:50–12:00 pm Shestak—Options for Correcting Implant Malposition

12:10–12:20 pm Higdon—Patient Safety in Aesthetic Breast Surgery


12:30 pm Meeting Adjourns

.20

.20

VISIT PREVENACASES.COM FOR MORE INFORMATION

The incision management system with the MOST published clinical evidence.*

*Among negative pressure based incision management system

NOTE: Specific indications, contraindications, warnings, precautions and safety information exist for PREVENA™ Therapy. Please consult the applicable PREVENA™ System Clinician Guide instructions for use prior to application. Rx only.Copyright 2018 KCI Licensing, Inc. All rights reserved. Unless otherwise designated, all trademarks are proprietary to KCI Licensing, Inc., its affiliates and/or licensors. PRA-PM-US-00712 (12/18)

PREVENA™ Incision Management System and PREVENA PLUS™ Incision Management System Manages and Protects Surgical Incisions by:

• Delivering continuous negative pressure at -125mmHg for up to 7 days

• Helping hold incision edges together• Removing fluids and infectious materials

into a canister• Protecting the incision from external

infectious sources

1 12/12/2018 9:51:28 PM



2019 ATLANTA BREAST SURGERY SYMPOSIUM DISCLOSURES

*Planner/Reviewer

Amy Alderman, MD . . . . . . . . . . . .Nothing to discloseMitchell Brown, MD . . . . . . . . . . . .Nothing to discloseLouis Bucky, MD . . . . . . . . . . . . . .Board member and investor with Patient FIM. Bradley Calobrace, MD . . . . . . . .Nothing to discloseAbhishek Chatterjee, MD . . . . . . . . .Consultant with KCI & Medtronic—receives consulting feesMark Clemens, MD . . . . . . . . . . . .Nothing to discloseMark Codner, MD*. . . . . . . . . . . . .Nothing to discloseL. Franklyn Elliott, MD* . . . . . . . . .Nothing to discloseStephan Finical, MD* . . . . . . . . . . .Consultant with Allergan—receives consulting feesElizabeth Hall-Findlay, MD . . . . . . . .Author and editor with Lippincott, author with Thieme, editor with Elsevier—

receives royaltiesDennis Hammond, MD . . . . . . . . . .Consultant with Mentor, MTF, Establishment Labs, Nova Plasma Ltd.—receives

consulting fees; author with Elsevier—receives royaltiesKent Higdon, MD . . . . . . . . . . . . . .Nothing to discloseScott Hollenbeck, MD* . . . . . . . . . .Nothing to discloseRam Kalus, MD . . . . . . . . . . . . . . .Nothing to discloseSuhail Kanchwala, MD . . . . . . . . . .Consultant with Allergan—receives consulting feesCarmen Kavali, MD* . . . . . . . . . . .Consultant, speaker and trainer with Allergan—receives consulting fees John Kim, MD . . . . . . . . . . . . . . . .Researcher with MTF—receives funding support; equity member of Surgical

Innovation AssociatesPeter Lennox, MD . . . . . . . . . . . . .Consultant with Allergan and Motiva—receives consulting feesMark Leyngold, MD* . . . . . . . . . . .Nothing to discloseAlbert Losken, MD* . . . . . . . . . . . .Consultant with RTI SurgicalPatrick Mallucci, MD . . . . . . . . . . . .Shareholder with Polytech—receives teaching feesBruce Mast, MD*. . . . . . . . . . . . . .Stock holder with Axogen; author with Thieme Publishing—receives royaltiesThomas McFadden, MD* . . . . . . . .Nothing to discloseKurtis Moyer, MD* . . . . . . . . . . . . .Nothing to discloseMaurice Nahabedian, MD . . . . . . . .Speaker with Allergan—receives consulting fees; Chief Surgical Officer with

Polarity TE—receives a salaryJames Namnoum, MD* . . . . . . . . .Nothing to disclose



Peter Per Heden, MD . . . . . . . . . . .Consultant and stockholder with Establishment Labs - receives consulting fees; Consultant with Allergan and Mentor; Shareholder with Novus Scientific; Shareholder and founder with Ipomia and Novoaim.

David Plank, MD* . . . . . . . . . . . . .Nothing to discloseTracy Pfeifer, MD . . . . . . . . . . . . . .Consultant with ANZU Medical; consultant with Sientra—receives consulting feesTroy Pittman, MD . . . . . . . . . . . . . .Advisory board member and speaker with Sientra and Stryker—receives

honorariumAndrea Pusic, MD . . . . . . . . . . . . . .Co-developer of BREAST-Q, FACE-Q & BODY-Q—receives royaltiesChristopher Runyan, MD* . . . . . . . .Nothing to discloseSusan Russell . . . . . . . . . . . . . . . .Nothing to discloseAra Salibian, MD . . . . . . . . . . . . . .Nothing to discloseErin Schwarz . . . . . . . . . . . . . . . . .Nothing to discloseKenneth Shestak, MD . . . . . . . . . . .Nothing to discloseSteven Teitelbaum, MD . . . . . . . . . .Board member and researcher with Establishment Labs—receives stock &

quarterly paymentsJennifer Walden, MD . . . . . . . . . . .Investigator & advisor with Vieve; luminary & advisor with Thermi & Sciton;

luminary with Venus Concepts, Vision Medical, Cynosure & BTL; investor & investigator with InMode; shareholder & luminary with JoyLux; investor with HintMD & Ideal Implant; speaker & luminary with Lumenis; author with Elsevier—receives honoraria from Sciton, BTL, InMode & Lumenis—receives royalties from Elsevier

Simeon Wall, Jr., MD . . . . . . . . . . .Stockholder/founder Strathspey Crown; stockholder with Establishment Labs; Educator with QMP—receives royalties; founder SurgiStem Technologies—receives nothing

ACCREDITATIONThe Southeastern Society of Plastic and Reconstructive Surgeons is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide medical education for physicians.

The Southeastern Society of Plastic and Reconstructive Surgeons designates this live activity for MAXIMUM OF 20.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Of the 20.75 credits, 3.50 have been identified as applicable to patient safety. p

The Southeastern Society Gratefully Acknowledges Commercial Support from MENTOR WORLDWIDE

THE 62ND ANNUAL SC IENT I F IC MEET ING OF THE SOUTHEASTERN SOCIETY OF PLAST IC AND RECONSTRUCT IVE SURGEONS

The Ritz-Carlton | Naples, Florida

Registration Opens Soon

Save the DateJ U N E 8 –12 , 2 019

HOW TO ACHIEVE GOOD RESULTS€¦ · • Planned radiation therapy to the breast following breast...

Documents

Transcript of HOW TO ACHIEVE GOOD RESULTS€¦ · • Planned radiation therapy to the breast following breast...